HIV Citation List: December 7 - December 20, 2012

PubMed citations

1. Antiviral Agents Derived from Novel 1-Adamantyl Singlet Nitrenes. Antiviral Chemistry & Chemotherapy, 2012. [Epub ahead of print]; PMID[23234699].

[PubMed]. HIV_1207-122012.

2. Short-peptide Fusion Inhibitors with High Potency against Wild-type and Enfuvirtide-resistant HIV-1. Chong, H., X. Yao, Z. Qiu, J. Sun, M. Zhang, S. Waltersperger, M. Wang, S.L. Liu, S. Cui, and Y. He. Federation of American Societies for Experimental Biology Journal, 2012. [Epub ahead of print]; PMID[23233535].

[PubMed]. HIV_1207-122012.

3. MiniCD4 Microbicide Prevents HIV Infection of Human Mucosal Explants and Vaginal Transmission of SHIV(162P3) in Cynomolgus macaques. Dereuddre-Bosquet, N., L. Morellato-Castillo, J. Brouwers, P. Augustijns, K. Bouchemal, G. Ponchel, O.H. Ramos, C. Herrera, M. Stefanidou, R. Shattock, L. Heyndrickx, G. Vanham, P. Kessler, R. Le Grand, and L. Martin. PLoS Pathogens, 2012. 8(12): p. e1003071. PMID[23236282].

[PubMed]. HIV_1207-122012.

4. Identification of a 3-Aminoimidazo[1,2-a]pyridine Inhibitor of HIV-1 Reverse Transcriptase. Elleder, D., T.J. Baiga, R.L. Russell, J.A. Naughton, S.H. Hughes, J.P. Noel, and J.A. Young. Virology Journal, 2012. 9(1): p. 305. PMID[23231773].

[PubMed]. HIV_1207-122012.

5. Amniotic Fluid Exhibits an Innate Inhibitory Activity Against HIV Type 1 Replication In vitro. Farzin, A., P. Boyer, B. Ank, K. Nielsen-Saines, and Y. Bryson. AIDS Research Human Retroviruses, 2012. [Epub ahead of print]; PMID[22998428].

[PubMed]. HIV_1207-122012.

6. 3-Hydroxyphthalic Anhydride-modified Human Serum Albumin as a Microbicide Candidate Inhibits HIV Infection by Blocking Viral Entry. Li, L., J. Qiu, L. Lu, S. An, P. Qiao, S. Jiang, and S. Liu. J Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[23221626].

[PubMed]. HIV_1207-122012.

7. Kadcoccitones a and B, Two New 6/6/5/5-fused Tetracyclic Triterpenoids from Kadsura coccinea. Liang, C.Q., Y.M. Shi, R.H. Luo, X.Y. Li, Z.H. Gao, X.N. Li, L.M. Yang, S.Z. Shang, Y. Li, Y.T. Zheng, H.B. Zhang, W.L. Xiao, and H.D. Sun. Organic Letters, 2012. [Epub ahead of print]; PMID[23230829].

[PubMed]. HIV_1207-122012.

8. Efficient Mucosal Transmissibility but Limited Pathogenicity of R5 SHIVSF162P3N in Chinese Origin Rhesus macaques. Mumbauer, A., A. Gettie, J. Blanchard, and C. Cheng-Mayer. Journal of Acquired Immune Deficiency Syndromes, 2012. [Epub ahead of print]; PMID[23221980].

[PubMed]. HIV_1207-122012.

9. Design of Highly Potent HIV Fusion Inhibitors Based on Artificial Peptide Sequences. Shi, W., L. Cai, L. Lu, C. Wang, K. Wang, L. Xu, S. Zhang, H. Han, X. Jiang, B. Zheng, S. Jiang, and K. Liu. Chemical Communications, 2012. 48(94): p. 11579-11581. PMID[23093045].

[PubMed]. HIV_1207-122012.

10. Inhibition of HIV-1 Capsid Assembly: Optimization of the Antiviral Potency by Site Selective Modifications at N1, C2 and C16 of a 5-(5-Furan-2-yl-pyrazol-1-yl)-1H-benzimidazole Scaffold. Tremblay, M., P. Bonneau, Y. Bousquet, P. Deroy, J. Duan, M. Duplessis, A. Gagnon, M. Garneau, N. Goudreau, I. Guse, O. Hucke, S.H. Kawai, C.T. Lemke, S.W. Mason, B. Simoneau, S. Surprenant, S. Titolo, and C. Yoakim. Bioorganic & Medicinal Chemistry Letters, 2012. 22(24): p. 7512-7517. PMID[23122820].

[PubMed]. HIV_1207-122012.

11. 6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 Integrase Inhibitors. Zhao, X.Z., K. Maddali, S.J. Smith, M. Metifiot, B.C. Johnson, C. Marchand, S.H. Hughes, Y. Pommier, and T.R. Burke, Jr. Bioorganic & Medicinal Chemistry Letters, 2012. 22(24): p. 7309-7313. PMID[23149229]. [PubMed]. HIV_1207-122012.

ISI Web of Knowledge Citations

12. Discovery of Novel 2-(3-(2-Chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as Potent HIV-1 Inhibitors Using a Structure-based Bioisosterism Approach. Zhan, P., W.M. Chen, Z.Y. Li, X. Li, X.W. Chen, Y. Tian, C. Pannecouque, E. De Clercq, and X.Y. Liu. Bioorganic & Medicinal Chemistry, 2012. 20(23): p. 6795-6802. ISI[000311190000001].

[WOS]. HIV_1207-122012.

13. Structure-based Bioisosterism Design, Synthesis and Biological Evaluation of Novel 1,2,4-Triazin-6-ylthioacetamides as Potent HIV-1 NNTRIs. Zhan, P., X. Li, Z.Y. Li, X.W. Chen, Y. Tian, W.M. Chen, X.Y. Liu, C. Pannecouque, and E. De Clercq. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7155-7162. ISI[000310583100034].

[WOS]. HIV_1207-122012.

14. POMA Analyses as New Efficient Bioinformatics' Platform to Predict and Optimize Bioactivity of Synthesized 3a,4-Dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide Analogues. Ahsan, M.J., J. Govindasamy, H. Khalilullah, G. Mohan, J.P. Stables, C. Pannecouque, and E. De Clercq. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7029-7035. ISI[000310583100006].

[WOS]. HIV_1207-122012.

15. The Nonnucleoside Reverse Transcription Inhibitor MIV-160 Delivered from an Intravaginal Ring, but Not from a Carrageenan Gel, Protects against Simian/Human Immunodeficiency Virus-RT Infection. Aravantinou, M., R. Singer, N. Derby, G. Calenda, P. Mawson, C.J. Abraham, R. Menon, S. Seidor, D. Goldman, J. Kenney, G. Villegas, A. Gettie, J. Blanchard, J.D. Lifson, M. Piatak, J.A. Fernandez-Romero, T.M. Zydowsky, N. Teleshova, and M. Robbiani. AIDS Research and Human Retroviruses, 2012. 28(11): p. 1467-1475. ISI[000310754100011].

[WOS]. HIV_1207-122012.

16. Sphingopeptides: Dihydrosphingosine-based Fusion Inhibitors against Wild-type and Enfuvirtide-resistant HIV-1. Ashkenazi, A., M. Viard, L. Unger, R. Blumenthal, and Y. Shai. Federation of American Societies for Experimental Biology Journal, 2012. 26(11): p. 4628-4636. ISI[000310574200024].

[WOS]. HIV_1207-122012.

17. Design and Docking Studies of Some Novel 1-Phenyl-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]Indole-3-carboxylic Acids as Inhibitors of Human Immunodeficiency Virus Type-1 Reverse Transcriptase. Ashok, P., K.K. Babu, S. Murugesan, and S. Ganguly. Asian Journal of Chemistry, 2012. 24(12): p. 5857-5860. ISI[000310771200120].

[WOS]. HIV_1207-122012.

18. Platinum(II) and Gold(I) Complexes Based on 1,1'-bis(Diphenylphosphino)metallocene Derivatives: Synthesis, Characterization and Biological Activity of the Gold Complexes. Bjelosevic, H., I.A. Guzei, L.C. Spencer, T. Persson, F.H. Kriel, R. Hewer, M.J. Nell, J. Gut, C.E.J. van Rensburg, P.J. Rosenthal, J. Coates, J. Darkwa, and S.K.C. Elmroth. Journal of Organometallic Chemistry, 2012. 720: p. 52-59. ISI[000310765400008].

[WOS]. HIV_1207-122012.

19. Ultrasensitive Allele-specific PCR Reveals Rare Preexisting Drug-resistant Variants and a Large Replicating Virus Population in macaques Infected with a Simian Immunodeficiency Virus Containing Human Immunodeficiency Virus Reverse Transcriptase. Boltz, V.F., Z. Ambrose, M.F. Kearney, W. Shao, V.N. KewalRamani, F. Maldarelli, J.W. Mellors, and J.M. Coffin. Journal of Virology, 2012. 86(23): p. 12525-12530. ISI[000310585300006].

[WOS]. HIV_1207-122012.

20. Synthetic Bicyclic Iminosugar Derivatives Fused Thiazolidin-4-one as New Potential HIV-RT Inhibitors. Chen, H., T.Y. Yang, S.N. Wei, H.Z. Zhang, R. Li, Z.B. Qin, and X.L. Li. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7041-7044. ISI[000310583100008].

[WOS]. HIV_1207-122012.

21. Anti-HIV-1 Activity of Resveratrol Derivatives and Synergistic Inhibition of HIV-1 by the Combination of Resveratrol and Decitabine. Clouser, C.L., J. Chauhan, M.A. Bess, J.L. van Oploo, D. Zhou, S. Dimick-Gray, L.M. Mansky, and S.E. Patterson. Bioorganic & Medicinal Chemistry Letters, 2012. 22(21): p. 6642-6646. ISI[000310353600022].

[WOS]. HIV_1207-122012.

22. Long-acting Nanoformulated Antiretroviral Therapy Elicits Potent Antiretroviral and Neuroprotective Responses in HIV-1-Infected Humanized Mice. Dash, P.K., H.E. Gendelman, U. Roy, S. Balkundi, Y. Alnouti, R.L. Mosley, H.A. Gelbard, J. McMillan, S. Gorantla, and L.Y. Poluektova. AIDS, 2012. 26(17): p. 2135-2144. ISI[000310750800002].

[WOS]. HIV_1207-122012.

23. Membrane-anchored and Secreted C Peptides as HIV Entry Inhibitors. Egerer, L., J. Kimpel, K. Schmidt, F. Brauer, A. Volk, and D. von Laer. Human Gene Therapy, 2012. 23(10): p. A118-A119. ISI[000310364400357].

[WOS]. HIV_1207-122012.

24. New Anthraquinone Derivatives as Inhibitors of the HIV-1 Reverse Transcriptase-associated Ribonuclease H Function. Esposito, F., A. Corona, L. Zinzula, T. Kharlamova, and E. Tramontano. Chemotherapy, 2012. 58(4): p. 299-307. ISI[000311043700006].

[WOS]. HIV_1207-122012.

25. Structural Modifications of 5,6-Dihydroxypyrimidines with anti-HIV Activity. Guo, D.L., X.J. Zhang, R.R. Wang, Y. Zhou, Z. Li, J.Y. Xu, K.X. Chen, Y.T. Zheng, and H. Liu. Bioorganic & Medicinal Chemistry Letters, 2012. 22(23): p. 7114-7118. ISI[000310583100025].

[WOS]. HIV_1207-122012.

26. Identification of Old Drugs as Potential Inhibitors of HIV-1 Integrase-Human Ledgf/P75 Interaction Via Molecular Docking. Hu, G.P., X. Li, X.Q. Sun, W.Q. Lu, G.X. Liu, J. Huang, X. Shen, and Y. Tang. Journal of Molecular Modeling, 2012. 18(12): p. 4995-5003. ISI[000311400100004].

[WOS]. HIV_1207-122012.

27. Characterization of Peripheral and Mucosal Immune Responses in Rhesus macaques on Long-term Tenofovir and Emtricitabine Combination Antiretroviral Therapy. Jasny, E., S. Geer, I. Frank, P. Vagenas, M. Aravantinou, A.M. Salazar, J.D. Lifson, M. Piatak, A. Gettie, J.L. Blanchard, and M. Robbiani. Journal of Acquired Immune Deficiency Syndromes, 2012. 61(4): p. 425-435. ISI[000311083200007].

[WOS]. HIV_1207-122012.

28. Novel anti-HIV-1 Activity Produced by Conjugating Unsulfated Dextran with Poly-L-lysine and Characterization of the Unique Antiviral Mechanism. Kano, F., T. Otsuki, K. Nakamura, H. Mori, H. Hoshino, H. Sakagami, and H. Ogawa. Glycobiology, 2012. 22(11): p. 1638-1639. ISI[000310368700358].

[WOS]. HIV_1207-122012.

29. A Single Dose of a MIV-150/Zinc Acetate Gel Provides 24 H of Protection against Vaginal Simian Human Immunodeficiency Virus Reverse Transcriptase Infection, with More Limited Protection Rectally 8-24 H after Gel Use. Kenney, J., R. Singer, N. Derby, M. Aravantinou, C.J. Abraham, R. Menon, S. Seidor, S.M. Zhang, A. Gettie, J. Blanchard, M. Piatak, J.D. Lifson, J.A. Fernandez-Romero, T.M. Zydowsky, and M. Robbiani. AIDS Research and Human Retroviruses, 2012. 28(11): p. 1476-1484. ISI[000310754100012].

[WOS]. HIV_1207-122012.

30. Synthesis, Evaluation of anti-HIV-1 and anti-HCV Activity of Novel 2',3'-Dideoxy-2',2'-difluoro-4'-azanucleosides. Martinez-Montero, S., S. Fernandez, Y.S. Sanghvi, E.A. Theodorakis, M.A. Detorio, T.R. McBrayer, T. Whitaker, R.F. Schinazi, V. Gotor, and M. Ferrero. Bioorganic & Medicinal Chemistry, 2012. 20(23): p. 6885-6893. ISI[000311190000012].

[WOS]. HIV_1207-122012.

31. Expression of a Fusion Inhibitor and a CCR5 Agonist by Lentiviral Vectors Confers Protection against HIV Infection in vitro: Assessment of Efficacy In vivo in a New Humanized Mice Model of HIV Infection. Nicolas, P., L. Sidonie, B. Aude, D. Karim, M. Anne-Genevieve, G. Guy, and M. Gilles. Human Gene Therapy, 2012. 23(10): p. A118-A118. ISI[000310364400356].

[WOS]. HIV_1207-122012.

32. Human Milk Glycosaminoglycans Inhibit HIV-1 Primary Isolates In vitro Infection. Rosas-Alquicira, G., I. Acosta-Blanco, S. Ortega-Francisco, L. Fuentes-Romero, D.S. Newburg, G.M. Ruiz-Palacios, Y. Mao, J. Zaia, and M. Viveros-Rogel. Glycobiology, 2012. 22(11): p. 1632-1632. ISI[000310368700339].

[WOS]. HIV_1207-122012.

33. Noncyclam Tetraamines Inhibit CXC Chemokine Receptor Type 4 and Target Glioma-initiating Cells. Ros-Blanco, L., J. Anido, R. Bosser, J. Este, B. Clotet, A. Kosoy, L. Ruiz-Avila, J. Teixido, J. Seoane, and J.I. Borrell. Journal of Medicinal Chemistry, 2012. 55(17): p. 7560-7570. ISI[000308675800019].

[WOS]. HIV_1207-122012.